
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>doi: 10.1007/bf00204853
pmid: 8614854
Early and accurate diagnosis of infection or neuropathy of the diabetic foot is the key to successful management. Angiopathy leads to ischemia which, in combination with peripheral neuropathy, predisposes to pedal skin ulceration, the precursor of osteomyelitis. Chronic hyperglycemia promotes production of glycosylated end products which accumulate on endothelial proteins, causing ischemia of the vasa nervorum. When combined with axonal degeneration of the sensory nerves, the result is hypertrophic neuroarthropathy. Should the sympathetic nerve fibers also be damaged, the resultant loss of vasoconstrictive impulses leads to hyperemia and atrophic neuroarthropathy. Plain radiography, although less sensitive than radionuclide, magnetic resonance (MR), and computed tomographic examinations, should be the initial procedure for imaging suspected osteomyelitis in the diabetic patient. If the radiographs are normal but the clinical suspicion of osteomyelitis is strong, a three-phase 99mTc-MDP scan or MR imaging is recommended. An equivocal 99mTc-MDP scan should be followed by MR imaging. To exclude osteomyelitis at a site of neuroarthropathy, a 111In white blood cell scan is preferable. To obtain a specimen of bone for bacteriological studies, percutaneous core biopsy is the procedure of choice, with the entrance of the needle well beyond the edge of the subjacent ulcer.
Diagnostic Imaging, Male, DIABETES MELLITUS, Biopsy, Clinical Sciences, Clinical sciences, Neurodegenerative, Technetium Tc 99m Medronate, Foot Diseases, Diabetic Neuropathies, Clinical Research, OSTEOMYELITIS, Needle, ANGIOPATHY, Humans, Radionuclide Imaging, Peripheral Neuropathy, Tomography, screening and diagnosis, Biomedical and Clinical Sciences, Diabetes, Pain Research, Biopsy, Needle, Neurosciences, Osteomyelitis, Middle Aged, Magnetic Resonance Imaging, NEUROARTHROPATHY, Diabetic Foot, 4.1 Discovery and preclinical testing of markers and technologies, X-Ray Computed, Detection, Nuclear Medicine & Medical Imaging, Biomedical Imaging, FOOT COMPLICATIONS, Female, Tomography, X-Ray Computed, Diabetic Angiopathies, 4.2 Evaluation of markers and technologies
Diagnostic Imaging, Male, DIABETES MELLITUS, Biopsy, Clinical Sciences, Clinical sciences, Neurodegenerative, Technetium Tc 99m Medronate, Foot Diseases, Diabetic Neuropathies, Clinical Research, OSTEOMYELITIS, Needle, ANGIOPATHY, Humans, Radionuclide Imaging, Peripheral Neuropathy, Tomography, screening and diagnosis, Biomedical and Clinical Sciences, Diabetes, Pain Research, Biopsy, Needle, Neurosciences, Osteomyelitis, Middle Aged, Magnetic Resonance Imaging, NEUROARTHROPATHY, Diabetic Foot, 4.1 Discovery and preclinical testing of markers and technologies, X-Ray Computed, Detection, Nuclear Medicine & Medical Imaging, Biomedical Imaging, FOOT COMPLICATIONS, Female, Tomography, X-Ray Computed, Diabetic Angiopathies, 4.2 Evaluation of markers and technologies
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 109 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
